Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
A review of more than 600,000 Finnish births from 2006 to 2016 found that mothers with type 1 diabetes had more than four times as many children born with heart defects.
Read Full NewsIn this Neuropathways piece, Kevin Chang, PharmD, explores the complexities of remyelination in multiple sclerosis and the potential of Wnt/β-catenin signaling as a therapeutic target.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on RBD as a prodromal marker for synucleinopathies!
Psoriatic Arthritis in 2025: Year in Review
Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval
1.
Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.
2.
'Next Berlin Patient' Adds to Small but Growing Number of People Cured of HIV
3.
Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.
4.
Q&A: Odds of surviving cancer drop drastically when credit score dips
5.
November 2023, Medical Bulletin 04/.
1.
From Bruises to Blood Clots: Everything You Need to Know about Hematoma
2.
Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment
3.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
4.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
5.
Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part V
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
3.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
5.
Navigating the Complexities of Ph Negative ALL - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge